BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumours to treat various types of cancer. BetterLife Pharma Inc. has a research agreement with the University of California San Diego for preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was founded in 2002 and is headquartered in Vancouver, Canada.

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

1875th out of 2,043 stocks

Pharmaceutical Preparations Industry

738th out of 770 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for BetterLife Pharma.

0.0 Community Rank

Outperform Votes
BetterLife Pharma has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
BetterLife Pharma has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about BetterLife Pharma and other stocks. Vote “Outperform” if you believe BETRF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BETRF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
BetterLife Pharma does not currently pay a dividend.
Dividend Growth
BetterLife Pharma does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, BetterLife Pharma insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 34.77% of the stock of BetterLife Pharma is held by insiders.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of BetterLife Pharma is -0.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of BetterLife Pharma is -0.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
BetterLife Pharma has a P/B Ratio of 4.25. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

BetterLife Pharma (OTCMKTS:BETRF) Frequently Asked Questions

What stocks does MarketBeat like better than BetterLife Pharma?

Wall Street analysts have given BetterLife Pharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but BetterLife Pharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting BetterLife Pharma?

BetterLife Pharma saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 800 shares, a decrease of 94.8% from the March 31st total of 15,500 shares. Based on an average daily trading volume, of 60,500 shares, the short-interest ratio is presently 0.0 days.
View BetterLife Pharma's Short Interest.

When is BetterLife Pharma's next earnings date?

BetterLife Pharma is scheduled to release its next quarterly earnings announcement on Monday, July 5th 2021.
View our earnings forecast for BetterLife Pharma.

Who are BetterLife Pharma's key executives?

BetterLife Pharma's management team includes the following people:

Dr. Ahmad Doroudian, Founder, CEO & Director (Age 61, Pay $133.33k)
Ms. Moira Ong C.A., CPA, CA, CFA, Chief Financial Officer (Age 46, Pay $120k)
Mr. Patrick Kroupa, Chief Psychedelics Officer
Mr. Justin Kirkland, Chief Psychedelics Scientist

Who are some of BetterLife Pharma's key competitors?

Some companies that are related to BetterLife Pharma include Can-Fite BioPharma (CANF), AngioSoma (SOAN), Hoth Therapeutics (HOTH), Petros Pharmaceuticals (PTPI), Generex Biotechnology (GNBT), RegeneRx Biopharmaceuticals (RGRX), NovaBay Pharmaceuticals (NBY), Integrated BioPharma (INBP), Immuron (IMRN), Alterity Therapeutics (ATHE), China Pharma (CPHI), Artelo Biosciences (ARTL), Akari Therapeutics (AKTX), Sonnet BioTherapeutics (SONN) and EyeGate Pharmaceuticals (EYEG).
View all of BETRF's competitors.

What is BetterLife Pharma's stock symbol?

BetterLife Pharma trades on the OTCMKTS under the ticker symbol "BETRF."

How do I buy shares of BetterLife Pharma?

Shares of BETRF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BetterLife Pharma's stock price today?

One share of BETRF stock can currently be purchased for approximately $0.51.

How much money does BetterLife Pharma make?

BetterLife Pharma has a market capitalization of $8.78 million.

How many employees does BetterLife Pharma have?

BetterLife Pharma employs 7 workers across the globe.

What is BetterLife Pharma's official website?

The official website for BetterLife Pharma is www.abetterlifepharma.com.

Where are BetterLife Pharma's headquarters?

BetterLife Pharma is headquartered at 1275 WEST 6TH AVENUE, VANCOUVER A1, V6H 1A6.

How can I contact BetterLife Pharma?

BetterLife Pharma's mailing address is 1275 WEST 6TH AVENUE, VANCOUVER A1, V6H 1A6. The company can be reached via phone at (604) 805-7783 or via email at [email protected]

This page was last updated on 5/8/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

BetterLife Pharma Stock Forecast, Price & News

Adding

Adding

Adding BetterLife Pharma Inc.

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Headlines

About BetterLife Pharma

MarketRank™

Overall MarketRank™